Big news in the weight-loss world this week: Oprah Winfrey is exiting WeightWatchers. The talkshow host has been the public face of the company for almost a decade but is stepping away from the board and donating all her shares to charity “to eliminate any perceived conflict of interest around her taking weight-loss medications”.

No prizes for guessing the weight-loss medications she’s talking about. Pretty much every celebrity and high net worth female (and a fair few men, including Elon Musk) seem to be injecting GLP-1 drugs. These drugs – the most famous of which is the diabetes medication Ozempic – stop you from feeling hungry and can result in dramatic weight loss. They’re seen as a no-effort way to slim down.

Winfrey’s move away from WeightWatchers isn’t just a professional transition – it marks a broader cultural shift. The dieting industry of yore is officially dead. As GLP-1 drugs like Ozempic explode in popularity, the idea of relying on will power to lose weight is becoming obsolete. So too is society’s short-lived flirtation with body positivity: thin is dangerously in again.

WeightWatchers, by the way, is well aware of all this. There’s a reason the company has been around for six decades: it has constantly shifted its positioning to try to reflect changing attitudes towards health and beauty. In 2018, amid the craze for wellness, for example, the company changed its name to WW and updated its mission to “Wellness that Works”. Now it’s moving away from wellness and leaning heavily into drugs, drugs, drugs. I’m not sure why Winfrey’s use of weight-loss drugs is framed as a “conflict of interest” considering WeightWatchers has gone all in on GLP-1 drugs. Last year the brand acquired a digital health company which allowed its members to get prescriptions to weight-loss medications and grandly announced that it had become a “digital health company”.

GLP-1 drugs are booming and will only become more popular. Still, while they may be widespread in celebrity circles, not everyone is shouting about their habit from the rooftops. There’s a certain coyness about taking the drugs because it is seen, to some degree, as “cheating”. Indeed Winfrey has previously said that she was initially wary about taking weight-loss drugs because it felt like an “easy way out”.

It’s silly, of course, to talk about “cheating” when it comes to weight loss. We all have different brains and bodies. Some people are more naturally prone to being thin than others – they have cheat-codes embedded in their DNA. But this sort of language, and the judgmental reaction to Winfrey’s GLP-1 use, does show how deeply weight is linked to morality in society. It lays bare the fact that we associate thinness with virtue. The fact that losing weight is now something you can easily take a drug for has the potential to massively disrupt this association.

“[This is a technology that will reorder society,” Paul Ford wrote in Wired last year in a piece about how Mounjaro (a similar drug to Ozempic) had changed his life. “I have been judged as greedy and weak since I was 10 years old – and now the sin is washed away. Baptism by injection.”

I’m not cheerleading GLP-1 drugs here, I should note. Far from it. They may be killing off one form of diet culture, but as the obsession with Winfrey’s recent weight loss shows, they’re simply ushering in another. Women are still very much judged by how much space they take up – technology is advancing a lot faster than our attitudes.

Abortion rights in France are currently protected by a 1975 law which, like all laws, could be revoked. Emmanuel Macron has said he wants to make women’s freedom to choose an abortion “irreversible”.

“Less than 4% of the artists in the [Metropolitan Museum of Art] Modern Art sections are women, but 76% of the nudes are female,” the activist art group Guerrilla Girls found in 2012. More than 10 years on the gender imbalance in museums is still very visible. To help redress this art historian Katy Hessel has created audio guides for museums that shift the spotlight on to female artists.

Scientists analyzed 62 placental tissue samples and found microplastics in every single one of them, raising concerns about the potential health impacts on developing foetuses.

Sign up to The Week in Patriarchy

Get Arwa Mahdawi’s weekly recap of the most important stories on feminism and sexism and those fighting for equality

after newsletter promotion

Humpback whales were observed having sex for the first time and – bit of a surprise – it turns out both whales were male. This was pretty easy to spot as a whale penis is two metres long, leaving, as one scientist put it, “little room for discussion that there is a sexual component to such behaviour”. In the Guardian, Philip Hoare looks more broadly at the queer sea and how such “flagrant” acts also “expose many of our human presumptions about sexuality, gender and identity”.

Federal officials have previously prosecuted hate crimes based on gender identity, but these cases never reached trial.

That’s according to a new book by the New York Times reporter Katie Rogers that claims Melania and Ivanka were engaged in a vicious “internal power struggle”.

Swift’s rise to world dominance continues apace.

I’m sure you don’t need a new scientific study to tell you that cats are complicated creatures – but researchers have come out with one anyway. The New York Times reports that a “new study suggests that a cat’s meows and other vocalizations are greatly misinterpreted and that people should consider both vocal and visual cues to try to determine what’s going on with their pets”. Or you could just get a dog: they are much more simple to deal with.

QOSHE - The Week in Patriarchy Brouhaha over Oprah on Ozempic shows technology advances faster than attitudes - Arwa Mahdawi
menu_open
Columnists Actual . Favourites . Archive
We use cookies to provide some features and experiences in QOSHE

More information  .  Close
Aa Aa Aa
- A +

The Week in Patriarchy Brouhaha over Oprah on Ozempic shows technology advances faster than attitudes

5 34
02.03.2024

Big news in the weight-loss world this week: Oprah Winfrey is exiting WeightWatchers. The talkshow host has been the public face of the company for almost a decade but is stepping away from the board and donating all her shares to charity “to eliminate any perceived conflict of interest around her taking weight-loss medications”.

No prizes for guessing the weight-loss medications she’s talking about. Pretty much every celebrity and high net worth female (and a fair few men, including Elon Musk) seem to be injecting GLP-1 drugs. These drugs – the most famous of which is the diabetes medication Ozempic – stop you from feeling hungry and can result in dramatic weight loss. They’re seen as a no-effort way to slim down.

Winfrey’s move away from WeightWatchers isn’t just a professional transition – it marks a broader cultural shift. The dieting industry of yore is officially dead. As GLP-1 drugs like Ozempic explode in popularity, the idea of relying on will power to lose weight is becoming obsolete. So too is society’s short-lived flirtation with body positivity: thin is dangerously in again.

WeightWatchers, by the way, is well aware of all this. There’s a reason the company has been around for six decades: it has constantly shifted its positioning to try to reflect changing attitudes towards health and beauty. In 2018, amid the craze for wellness, for example, the company changed its name to WW and updated its mission to........

© The Guardian


Get it on Google Play